Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20141
20172
20182
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting3
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Norwegian University of Science and Technology3
Amgen1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
Incyte Corporation1
Lund University Hospital1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma14
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Neoplasm Metastasis2
Anus Neoplasms1
Basal Cell Carcinoma1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.